Purchases and Sales Made in Q3 2021 in Supernus Pharmaceuticals, Inc. (SUPN)
This table provides information about the institutional ownership of Supernus Pharmaceuticals, Inc. (SUPN) during Q3 2021. The information is specifically focused on institutions that hold shares of SUPERNUS PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2021
Q3 2021
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-18.2K- 11.04% |
$430K - $573K
|
147K
$4.93M
|
|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
SELL
|
- |
-21.1K- 87.38% |
$497K - $662K
|
3.05K
$102K
|
|
|
Nov 10, 2021
Q3 2021
|
Bridge City Capital, LLC
Lake Oswego, OR |
SELL
|
- |
-28.9K- 20.97% |
$680K - $907K
|
109K
$3.65M
|
|
|
Nov 15, 2021
Q3 2021
|
Alberta Investment Management Corp
Edmonton, A0 |
SELL
|
- |
-31.5KClosed |
$742K - $989K
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-38.6KClosed |
$908K - $1.21M
|
0
$0
|
|
|
Nov 16, 2021
Q3 2021
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-56.5K- 13.51% |
$1.33M - $1.77M
|
362K
$12.1M
|
|
|
Nov 15, 2021
Q3 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-74K- 85.25% |
$1.74M - $2.32M
|
12.8K
$429K
|
|
|
Nov 15, 2021
Q3 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-85.2K- 14.02% |
$2M - $2.67M
|
522K
$17.5M
|
|
|
Nov 15, 2021
Q3 2021
|
First Trust Advisors LP
Wheaton, IL |
SELL
|
- |
-91.3K- 45.29% |
$2.15M - $2.86M
|
110K
$3.69M
|
|
|
Nov 15, 2021
Q3 2021
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-99.8K- 17.15% |
$2.35M - $3.13M
|
482K
$16.2M
|
|
|
Sep 21, 2023
Q3 2021
|
Jefferies Group LLC
New York, NY |
SELL
|
- |
-112K- 99.91% |
$2.65M - $3.53M
|
100
$3.35K
|
|
|
Nov 04, 2021
Q3 2021
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-114K- 30.75% |
$2.68M - $3.57M
|
256K
$8.58M
|
|
|
Nov 12, 2021
Q3 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-128K- 8.42% |
$3M - $4.01M
|
1.39M
$46.5M
|
|
|
Nov 04, 2021
Q3 2021
|
Lsv Asset Management
Chicago, IL |
SELL
|
- |
-157K- 80.8% |
$3.68M - $4.91M
|
37.2K
$1.25M
|
|
|
Oct 14, 2021
Q3 2021
|
Foundry Partners, LLC
|
SELL
|
- |
-168K- 90.53% |
$3.96M - $5.28M
|
17.6K
$590K
|
|
|
Nov 08, 2021
Q3 2021
|
Health Invest Partners Ab
|
SELL
|
- |
-195K- 36.79% |
$4.59M - $6.12M
|
335K
$11.2M
|
|
|
Oct 19, 2021
Q3 2021
|
Frontier Capital Management CO LLC
|
SELL
|
- |
-238K- 29.1% |
$5.59M - $7.46M
|
579K
$19.4M
|
|
|
Nov 15, 2021
Q3 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-389K- 96.23% |
$9.16M - $12.2M
|
15.2K
$511K
|
|
|
Nov 05, 2021
Q3 2021
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-414KClosed |
$9.74M - $13M
|
0
$0
|
|
|
Nov 10, 2021
Q3 2021
|
Fuller & Thaler Asset Management, Inc.
San Mateo, CA |
SELL
|
- |
-522K- 99.94% |
$12.3M - $16.4M
|
293
$9.82K
|